The clinically-proven digital psychological therapy for patients with depression
What is deprexis®?
10 modules tailored to your needs and preferences
Based on the answers you choose, deprexis® individualises its approach according to predefined algorithms and build your own course of chats adapted to your situation*.
Self-assessment of mood and severity of depression
On a regular basis, deprexis® invites you to assess your mood and the severity of your depression so that you can monitor your progress.
Exercises and summary sheets
Throughout the program, deprexis® offers exercises and summary sheets that can be used on a daily basis to help you cope with your depression.
Daily support
If you wish, deprexis® can send you a daily support by text message or e-mail.
In what way can digital therapy be adapted to treat depression?
There are still many difficulties in accessing optimal treatment for depression. They may be geographical or financial, linked to the lack of availability of psychiatrists and psychologists or to the fear of being stigmatised. Many patients also face long waiting times for access to psychotherapy.
Thanks to the flexibility and confidentiality of its online access, deprexis® allows you to access effective therapy, when you need it and regardless of the other treatments you are receiving for your depression1.
Are you a healthcare professional?
deprexis® has been studied in 12 randomised controlled trials in the most common care situations2-14.
Find out more about how deprexis was developed, how it works and whats benefits it can bring to your patients in your dedicated section.
deprexis® has proven its efficacy:
RCTs**
evaluating the efficacy and safety of deprexis® in the most common care situations2
patients
included in clinical studies evaluating the efficacy of deprexis®2
years
of clinical research consolidating the proof of efficacy of deprexis®
%
of patients in a study reported that deprexis® was helpful3
*Depending on your choices, deprexis® may offer you a selection of chats from the twelve available.
**RCTs = Randomized Controlled Studies
Intended use:
deprexis® is intended to provide therapeutic methods and exercises based on evidence-based psychological and psychotherapeutic therapies for patients with unipolar depression or depressive disorders, to help them managing their depression or depressive disorder. deprexis is intended as a self-application supplemental to care-as-usual for patients 18 years of age or older. deprexis can be used for a period of 90 days. deprexis is neither intended to replace treatment provided by a health care provider nor to provide information which is used to take decisions with diagnosis or therapeutic purposes.
Contraindications:
deprexis® should not be used by patients with bipolar disorder, psychotic disorder (e.g. schizophrenia) or by patients with suicidal risk.
Frequency of use:
Experience has shown that deprexis should ideally be used 1-2 times a week for at least half an hour for each session.
Instructions:
Read Instructions For Use carefully and follow its instructions. Available on www.ethypharm-digital-therapy.com/our-digital-therapies/deprexis/
Manufacturer:
GAIA AG – Hans-Henny-Jahnn-Weg 53 – 22085 Hamburg – Germany| www.gaia-group.com
Distributor:
Ethypharm Digital Therapy SAS - 194 Bureaux de la Colline - Bâtiment D - 92210 Saint-Cloud – France